F. Müller-Siecheneder

1.1k total citations
17 papers, 772 citations indexed

About

F. Müller-Siecheneder is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, F. Müller-Siecheneder has authored 17 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 3 papers in Neurology. Recurrent topics in F. Müller-Siecheneder's work include Schizophrenia research and treatment (6 papers), Neurological disorders and treatments (3 papers) and Bipolar Disorder and Treatment (3 papers). F. Müller-Siecheneder is often cited by papers focused on Schizophrenia research and treatment (6 papers), Neurological disorders and treatments (3 papers) and Bipolar Disorder and Treatment (3 papers). F. Müller-Siecheneder collaborates with scholars based in Germany, United Kingdom and United States. F. Müller-Siecheneder's co-authors include Hermann Wetzel, Otto Benkert, Thomas Messer, Sahar Latifi, Armin Szegedi, Matthias J. Müller, Frank Padberg, Astrid Zobel, Malek Bajbouj and Michael Trimble and has published in prestigious journals such as Psychological Medicine, Psychoneuroendocrinology and Psychiatry Research.

In The Last Decade

F. Müller-Siecheneder

17 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Müller-Siecheneder Germany 11 316 228 188 144 132 17 772
Ciarán Corcoran Ireland 8 326 1.0× 327 1.4× 173 0.9× 95 0.7× 179 1.4× 17 790
Roberto Delle Chiaie Italy 19 341 1.1× 233 1.0× 267 1.4× 62 0.4× 99 0.8× 49 916
Malte S. Depping Germany 17 313 1.0× 143 0.6× 422 2.2× 148 1.0× 134 1.0× 22 972
L. C. Scott United Kingdom 8 375 1.2× 199 0.9× 645 3.4× 229 1.6× 144 1.1× 9 1.2k
Déirdre Cooper‐Mahkorn Germany 8 303 1.0× 231 1.0× 318 1.7× 143 1.0× 352 2.7× 10 1.0k
Hugo D’Haenen Belgium 18 211 0.7× 258 1.1× 370 2.0× 161 1.1× 38 0.3× 35 981
Zafiris J. Daskalakis Canada 19 665 2.1× 216 0.9× 271 1.4× 272 1.9× 92 0.7× 41 992
A. Moffoot United Kingdom 14 293 0.9× 93 0.4× 441 2.3× 197 1.4× 95 0.7× 18 827
M. Ross United Kingdom 6 235 0.7× 95 0.4× 318 1.7× 218 1.5× 54 0.4× 8 623
Shahryar Rafi‐Tari Canada 9 372 1.2× 151 0.7× 549 2.9× 249 1.7× 127 1.0× 9 1.2k

Countries citing papers authored by F. Müller-Siecheneder

Since Specialization
Citations

This map shows the geographic impact of F. Müller-Siecheneder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Müller-Siecheneder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Müller-Siecheneder more than expected).

Fields of papers citing papers by F. Müller-Siecheneder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Müller-Siecheneder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Müller-Siecheneder. The network helps show where F. Müller-Siecheneder may publish in the future.

Co-authorship network of co-authors of F. Müller-Siecheneder

This figure shows the co-authorship network connecting the top 25 collaborators of F. Müller-Siecheneder. A scholar is included among the top collaborators of F. Müller-Siecheneder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Müller-Siecheneder. F. Müller-Siecheneder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Messer, Thomas, et al.. (2017). Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis. Psychiatry Research. 253. 338–350. 102 indexed citations
2.
Bajbouj, Malek, Angela Merkl, Thomas E. Schläepfer, et al.. (2010). Two-Year Outcome of Vagus Nerve Stimulation in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. 30(3). 273–281. 126 indexed citations
3.
Schläepfer, Thomas E., Caroline Frick, Astrid Zobel, et al.. (2008). Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychological Medicine. 38(5). 651–661. 144 indexed citations
4.
Juckel, Georg, Oliver Pogarell, Christoph Mulert, et al.. (2007). Differential Prediction of First Clinical Response to Serotonergic and Noradrenergic Antidepressants Using the Loudness Dependence of Auditory Evoked Potentials in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 68(8). 1206–1212. 86 indexed citations
5.
Mergl, Roland, Oliver Pogarell, Georg Juckel, et al.. (2007). Hand-Motor Dysfunction in Depression: Characteristics and Pharmacological Effects. Clinical EEG and Neuroscience. 38(2). 82–88. 18 indexed citations
6.
Mann, Klaus, Manfred J. Müller, F. Müller-Siecheneder, et al.. (2005). Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine. Psychoneuroendocrinology. 31(2). 256–264. 64 indexed citations
7.
Müller, Matthias J., Klaus Mann, J. Röschke, et al.. (2004). Subchronic Effects of Olanzapine on Sleep EEG in Schizophrenic Patients with Predominantly Negative Symptoms. Pharmacopsychiatry. 37(4). 157–162. 34 indexed citations
8.
Pogarell, Oliver, C. Schulz, F. Müller-Siecheneder, et al.. (2004). Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease. Pharmacopsychiatry. 36(5). 2 indexed citations
9.
Mergl, Roland, V. Henkel, Juergen Gallinat, et al.. (2004). Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*. Pharmacopsychiatry. 36(5). 1 indexed citations
10.
Rujescu, Dan, Ina Giegling, Norbert Dahmen, et al.. (2000). Association Study of Suicidal Behavior and Affective Disorders with a Genetic Polymorphism in ABCG1, a Positional Candidate on Chromosome 21q22.3. Neuropsychobiology. 42(Suppl. 1). 22–25. 10 indexed citations
11.
Müller, Matthias J., et al.. (1999). Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial. Psychiatry Research. 89(3). 275–280. 15 indexed citations
12.
Hegerl, Ulrich, et al.. (1999). [Depression and suicidal behavior more effectively controlled by a team approach. Pilot project to optimize diagnosis and therapy].. PubMed. 141(48). 43–5. 1 indexed citations
13.
Müller, Matthias J., et al.. (1998). Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS). Schizophrenia Research. 32(3). 151–160. 42 indexed citations
14.
Müller-Siecheneder, F., Matthias J. Müller, Andreas Hillert, et al.. (1998). Risperidone Versus Haloperidol and Amitriptyline in the Treatment of Patients With a Combined Psychotic and Depressive Syndrome. Journal of Clinical Psychopharmacology. 18(2). 111–120. 72 indexed citations
15.
Benkert, Otto, et al.. (1996). Negative and depressive symptoms in acute schizophrenic episodes-do they improve under neuroleptic treatment?. European Psychiatry. 11. 158s–159s. 2 indexed citations
16.
Gerbaldo, H. & F. Müller-Siecheneder. (1996). Über die Bedeutung der primären Negativsymptomatik bei schizophrenen und anderen psychiatrischen Patienten. Fortschritte der Neurologie · Psychiatrie. 64(6). 221–227. 2 indexed citations
17.
Benkert, Otto, F. Müller-Siecheneder, & Hermann Wetzel. (1995). Dopamine agonists in schizophrenia: a review. European Neuropsychopharmacology. 5. 43–53. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ciarán Corcoran Breakdown of academic impact, for papers by Roberto Delle Chiaie Breakdown of academic impact, for papers by Malte S. Depping Breakdown of academic impact, for papers by L. C. Scott Breakdown of academic impact, for papers by Déirdre Cooper‐Mahkorn Breakdown of academic impact, for papers by Hugo D’Haenen Breakdown of academic impact, for papers by Zafiris J. Daskalakis Breakdown of academic impact, for papers by A. Moffoot Breakdown of academic impact, for papers by M. Ross Breakdown of academic impact, for papers by Shahryar Rafi‐Tari
Rankless by CCL
2026